Remission of psoriasis during treatment with sorafenib Marloes S. van Kester, MD, PhD, Saskia A.C. Luelmo, MD, Maarten H. Vermeer, MD, PhD, Christian Blank, MD, PhD, Remco van Doorn, MD, PhD JAAD Case Reports Volume 4, Issue 10, Pages 1065-1067 (November 2018) DOI: 10.1016/j.jdcr.2018.09.009 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Before treatment with sorafenib. JAAD Case Reports 2018 4, 1065-1067DOI: (10.1016/j.jdcr.2018.09.009) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Almost complete clearance during treatment with sorafenib, 6 weeks after cessation of topical treatment. JAAD Case Reports 2018 4, 1065-1067DOI: (10.1016/j.jdcr.2018.09.009) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions